中国科学家在今年2月17日出版的英国权威医学杂志《柳叶刀》上发表论文宣布,他们发现了乙肝病毒特异多肽与热休克蛋白gp96的复合物,为慢性乙型肝炎、肝硬化和肝癌的免疫治疗开创了新的途径。 这项成果是由中国科学院微生物研究所分子病毒研究室的青年科 Chinese scientists published a paper on the Lancet, a leading British medical journal, published on February 17 this year, announcing that they have discovered a complex of the hepatitis B virus-specific polypeptide and the heat shock protein gp96, which is responsible for chronic hepatitis B, liver cirrhosis and liver cancer Immunotherapy has opened up new avenues. This result is from the Young Branch of the Molecular Virology Laboratory, Institute of Microbiology, Chinese Academy of Sciences